Pancreatic Endocrine Tumor Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014560539
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Pancreatic Endocrine Tumor Drug in global, including the following market information:
Global Pancreatic Endocrine Tumor Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pancreatic Endocrine Tumor Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Pancreatic Endocrine Tumor Drug companies in 2020 (%)
The global Pancreatic Endocrine Tumor Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pancreatic Endocrine Tumor Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic Endocrine Tumor Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pancreatic Endocrine Tumor Drug Market Segment Percentages, By Type, 2020 (%)
Buparlisib Hydrochloride
Dovitinib Lactate
Fosbretabulin Tromethamine
Lanreotide Acetate
MPHE-001B
Others

Global Pancreatic Endocrine Tumor Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pancreatic Endocrine Tumor Drug Market Segment Percentages, By Application, 2020 (%)
Clinic
Research Center
Hospital

Global Pancreatic Endocrine Tumor Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pancreatic Endocrine Tumor Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pancreatic Endocrine Tumor Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pancreatic Endocrine Tumor Drug revenues share in global market, 2020 (%)
Key companies Pancreatic Endocrine Tumor Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Pancreatic Endocrine Tumor Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen S.A.
Jiangsu Hengrui Medicine Co., Ltd.
MediaPharma s.r.l.
Novartis AG
OXiGENE, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pancreatic Endocrine Tumor Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic Endocrine Tumor Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic Endocrine Tumor Drug Overall Market Size
2.1 Global Pancreatic Endocrine Tumor Drug Market Size: 2021 VS 2027
2.2 Global Pancreatic Endocrine Tumor Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pancreatic Endocrine Tumor Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pancreatic Endocrine Tumor Drug Players in Global Market
3.2 Top Global Pancreatic Endocrine Tumor Drug Companies Ranked by Revenue
3.3 Global Pancreatic Endocrine Tumor Drug Revenue by Companies
3.4 Global Pancreatic Endocrine Tumor Drug Sales by Companies
3.5 Global Pancreatic Endocrine Tumor Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pancreatic Endocrine Tumor Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pancreatic Endocrine Tumor Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pancreatic Endocrine Tumor Drug Players in Global Market
3.8.1 List of Global Tier 1 Pancreatic Endocrine Tumor Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Pancreatic Endocrine Tumor Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pancreatic Endocrine Tumor Drug Market Size Markets, 2021 & 2027
4.1.2 Buparlisib Hydrochloride
4.1.3 Dovitinib Lactate
4.1.4 Fosbretabulin Tromethamine
4.1.5 Lanreotide Acetate
4.1.6 MPHE-001B
4.1.7 Others
4.2 By Type - Global Pancreatic Endocrine Tumor Drug Revenue & Forecasts
4.2.1 By Type - Global Pancreatic Endocrine Tumor Drug Revenue, 2016-2021
4.2.2 By Type - Global Pancreatic Endocrine Tumor Drug Revenue, 2022-2027
4.2.3 By Type - Global Pancreatic Endocrine Tumor Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Pancreatic Endocrine Tumor Drug Sales & Forecasts
4.3.1 By Type - Global Pancreatic Endocrine Tumor Drug Sales, 2016-2021
4.3.2 By Type - Global Pancreatic Endocrine Tumor Drug Sales, 2022-2027
4.3.3 By Type - Global Pancreatic Endocrine Tumor Drug Sales Market Share, 2016-2027
4.4 By Type - Global Pancreatic Endocrine Tumor Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic Endocrine Tumor Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Research Center
5.1.4 Hospital
5.2 By Application - Global Pancreatic Endocrine Tumor Drug Revenue & Forecasts
5.2.1 By Application - Global Pancreatic Endocrine Tumor Drug Revenue, 2016-2021
5.2.2 By Application - Global Pancreatic Endocrine Tumor Drug Revenue, 2022-2027
5.2.3 By Application - Global Pancreatic Endocrine Tumor Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Pancreatic Endocrine Tumor Drug Sales & Forecasts
5.3.1 By Application - Global Pancreatic Endocrine Tumor Drug Sales, 2016-2021
5.3.2 By Application - Global Pancreatic Endocrine Tumor Drug Sales, 2022-2027
5.3.3 By Application - Global Pancreatic Endocrine Tumor Drug Sales Market Share, 2016-2027
5.4 By Application - Global Pancreatic Endocrine Tumor Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pancreatic Endocrine Tumor Drug Market Size, 2021 & 2027
6.2 By Region - Global Pancreatic Endocrine Tumor Drug Revenue & Forecasts
6.2.1 By Region - Global Pancreatic Endocrine Tumor Drug Revenue, 2016-2021
6.2.2 By Region - Global Pancreatic Endocrine Tumor Drug Revenue, 2022-2027
6.2.3 By Region - Global Pancreatic Endocrine Tumor Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Pancreatic Endocrine Tumor Drug Sales & Forecasts
6.3.1 By Region - Global Pancreatic Endocrine Tumor Drug Sales, 2016-2021
6.3.2 By Region - Global Pancreatic Endocrine Tumor Drug Sales, 2022-2027
6.3.3 By Region - Global Pancreatic Endocrine Tumor Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pancreatic Endocrine Tumor Drug Revenue, 2016-2027
6.4.2 By Country - North America Pancreatic Endocrine Tumor Drug Sales, 2016-2027
6.4.3 US Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.4.4 Canada Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.4.5 Mexico Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pancreatic Endocrine Tumor Drug Revenue, 2016-2027
6.5.2 By Country - Europe Pancreatic Endocrine Tumor Drug Sales, 2016-2027
6.5.3 Germany Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.4 France Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.5 U.K. Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.6 Italy Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.7 Russia Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.8 Nordic Countries Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.5.9 Benelux Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pancreatic Endocrine Tumor Drug Revenue, 2016-2027
6.6.2 By Region - Asia Pancreatic Endocrine Tumor Drug Sales, 2016-2027
6.6.3 China Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.6.4 Japan Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.6.5 South Korea Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.6.6 Southeast Asia Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.6.7 India Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pancreatic Endocrine Tumor Drug Revenue, 2016-2027
6.7.2 By Country - South America Pancreatic Endocrine Tumor Drug Sales, 2016-2027
6.7.3 Brazil Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.7.4 Argentina Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pancreatic Endocrine Tumor Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pancreatic Endocrine Tumor Drug Sales, 2016-2027
6.8.3 Turkey Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.8.4 Israel Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
6.8.6 UAE Pancreatic Endocrine Tumor Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Ipsen S.A.
7.1.1 Ipsen S.A. Corporate Summary
7.1.2 Ipsen S.A. Business Overview
7.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Major Product Offerings
7.1.4 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.1.5 Ipsen S.A. Key News
7.2 Jiangsu Hengrui Medicine Co., Ltd.
7.2.1 Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
7.2.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
7.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Major Product Offerings
7.2.4 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.2.5 Jiangsu Hengrui Medicine Co., Ltd. Key News
7.3 MediaPharma s.r.l.
7.3.1 MediaPharma s.r.l. Corporate Summary
7.3.2 MediaPharma s.r.l. Business Overview
7.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Major Product Offerings
7.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.3.5 MediaPharma s.r.l. Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Major Product Offerings
7.4.4 Novartis AG Pancreatic Endocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.4.5 Novartis AG Key News
7.5 OXiGENE, Inc.
7.5.1 OXiGENE, Inc. Corporate Summary
7.5.2 OXiGENE, Inc. Business Overview
7.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Major Product Offerings
7.5.4 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales and Revenue in Global (2016-2021)
7.5.5 OXiGENE, Inc. Key News
8 Global Pancreatic Endocrine Tumor Drug Production Capacity, Analysis
8.1 Global Pancreatic Endocrine Tumor Drug Production Capacity, 2016-2027
8.2 Pancreatic Endocrine Tumor Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Pancreatic Endocrine Tumor Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pancreatic Endocrine Tumor Drug Supply Chain Analysis
10.1 Pancreatic Endocrine Tumor Drug Industry Value Chain
10.2 Pancreatic Endocrine Tumor Drug Upstream Market
10.3 Pancreatic Endocrine Tumor Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pancreatic Endocrine Tumor Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pancreatic Endocrine Tumor Drug in Global Market
Table 2. Top Pancreatic Endocrine Tumor Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pancreatic Endocrine Tumor Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pancreatic Endocrine Tumor Drug Revenue Share by Companies, 2016-2021
Table 5. Global Pancreatic Endocrine Tumor Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Pancreatic Endocrine Tumor Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pancreatic Endocrine Tumor Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Pancreatic Endocrine Tumor Drug Product Type
Table 9. List of Global Tier 1 Pancreatic Endocrine Tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Endocrine Tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Ipsen S.A.
Jiangsu Hengrui Medicine Co., Ltd.
MediaPharma s.r.l.
Novartis AG
OXiGENE, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE